| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner | Director +1 more
8 companies
Pfizer Inc is a 10% Owner at Allogene Therapeutics, Inc. with holdings across 8 companies. Recent SEC Form 4 filings include 7 buys and 3 sells.
Estimated insider holdings value: $232.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | PFE Pfizer Inc | 10% Owner | Buy | 1,811,594 | $2.76 | $4,999,999.44 | +43.8% | -0.9% | -30.3% | |
| Oct 27, 2020 | PFE Pfizer Inc | 10% Owner | Buy | 1,200,000 | $10.00 | $12,000,000.00 | +4.6% | - | - | |
| Jun 3, 2020 | QNCX Quince Therapeutics, Inc. | 10% Owner | Sell | 370,000 | $40.18 | $14,866,600.00 | -11.4% | - | - | |
| Mar 16, 2020 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +26.7% | - | - | |
| May 13, 2019 | QNCX Quince Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $17.00 | $850,000.00 | +1.6% | - | - | |
| Nov 15, 2018 | ICUI Icu Medical Inc/de | Director | Sell | 2,500,000 | $209.25 | $523,125,000.00 | -100% | - | - | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | 10% Owner | Buy | 55,556 | $18.00 | $1,000,008.00 | +0.3% | - | - | |
| Aug 13, 2018 | ICUI Icu Medical Inc/de | Director, 10% Owner | Sell | 700,000 | $284.35 | $199,045,000.00 | -21.9% | - | - | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner | Buy | 40,000 | $17.00 | $680,000.00 | +2.9% | - | - | |
| Oct 6, 2015 | SYBX Synlogic, Inc. | 10% Owner | Buy | 714,285 | $7.00 | $4,999,995.00 | +46.4% | - | - |